20 stocks with very bullish concalls which can double revenue in next 2-3 years:
🔹1. Bhagyanagar Industries (#BHAGYANGR): 25% revenue growth CAGR for next 3-4 years
🔹2. Frontier Springs (#FRONTSP): 30% revenue growth guidance in FY-27
🔹3. Enviro Infra Engineers (#EIEL): 35-40% revenue growth guidance in FY-27
🔹4. VA Tech Wabag (#WABAG): 20% revenue growth guidance in FY-27
🔹5. Tinna Rubber (#TINNARUBR): 25% revenue growth guidance in FY-27
🔹6. Namo-Ewaste (#WABAG): 40-50% revenue growth guidance in FY-27
🔹7. Baheti Recycling (#BAHETI): 30% revenue growth guidance in FY-27
🔹8. Rossell Techsys (#ROSSTECH): 80-90% revenue growth in FY-27
🔹9. Supreme Power Equipments (#SUPREMEPWR): 50% revenue growth guidance in FY-27 and FY-28
🔹10. Transformers and Rectifiers India (#TARIL): 40% revenue growth CAGR for next 3 years
🔹11. Premier Energies (#PREMIERENE): 3-4x FY-26 revenue in next 3 years
🔹12. Airfloa Tech (#AIRFLOA): 50% revenue growth guidance in FY-27 and FY-28
🔹13. Stallion Fluorochemicals (#STALLION): 30-35% revenue growth guidance in FY-27
🔹14. Anand Rathi Wealth (#ANANDRATHI): 18% revenue growth guidance in FY-27
🔹15. Sky Gold and Diamonds(#SKYGOLD): 30-35% revenue growth guidance in FY-27
🔹16. Knowledge Marine (#KMEW): 30% revenue growth guidance in FY-27 and FY-28
🔹17. NPST (#NPST): 70% revenue growth CAGR for next 3 years
🔹18. Premier Explosives (#PREMEXPLN): 55-80% revenue growth guidance in FY-27
🔹19. Ratnaveer Precision (#RATNAVEER): 30% revenue growth guidance in FY-27
🔹20. Timex (#TIMEX): 30% revenue growth guidance in FY-27
Follow @AdityaMittal795 for more such posts and educational content.
37 High-Quality Small-Cap Stocks to Study Closely ❤️🔥❤️
Quality Power
Anant Raj
TD Power
TARIL
Blackbuck
Interarch
Transrail
Krishna Defence
Syrma SGS
Vintage Coffee
V2 Retail
Tenneco Clean
Netweb
Yatharth Hospital
Pondy Oxides (POCL)
SKM Egg
Shilchar
Apollo Micro Systems
Lumax Auto
ACME Solar
Knowledge Marine
Pricol
Fiem Industries
Aditya Infotech
Yatra Online
CCL Products
Jain Resource Recycling
Astra Microwave
Atlanta Electricals
Acutaas Chemicals
Dr Agarwals Health Care
Can Fin Homes
Krishana Phoschem
Frontier Springs
Pace Digitek
Senores Pharma
Ashapura Minechem
How Investors Should Use This List 📒👇
This list is not about quick trades or short-term excitement.
It’s about quality businesses that deserve serious study ✅
As markets prepare for the next phase of the bull cycle, the real edge won’t come from chasing momentum - it will come from preparation. Studying businesses before they are in the spotlight is where long-term wealth is quietly built.
Every company in this list operates in a segment with structural tailwinds, policy support, or long visibility of demand. These are businesses where management execution, balance sheet strength, and industry positioning actually matter.
📌 But remember - not every stock is for everyone.
The purpose is to track, study, and filter ✅
Go through their 👇
1. Annual reports
2. Conference call transcripts
3. Balance sheets and cash-flow statements
4. Industry trends and competitive positioning
Understand how the business makes money, where it reinvests, and how it handles cycles. Over time, a few names will naturally start making more sense to you than others - and that’s exactly where your focus should be.
👍 The next bull run will reward:
1. Those who did the work early
2. Those who tracked patiently
3. Those who waited for the right entry, not the perfect story
📌 Quality businesses don’t need daily validation from prices. They need time, discipline, and clarity of thought.
📌 Study first. Track deeply. Capital will follow clarity.
Disclaimer: This post is strictly for educational and informational purposes only. It does not constitute investment advice, a recommendation, or a solicitation to buy or sell any securities.
Epack Prefab – Execution Radar: Metrics, Signals & Rerating Indicators to Track
- What will truly drive the rerating ? Monitor these inflection checkpoints
1 | Market Share Shift: 5.5% → 10%
- EPACK isn’t trying to just grow, it is trying to take share.
▪️ Speed-led execution is becoming its brand moat
▪️ Repeat orders from marquee clients validate capability
▪️ Larger project pre-qualifications are now opening up
➡️ If Epack proves share capture, market stops valuing it as a cyclical PEB vendor and starts treating it as category consolidator.
2 | Capex Monetisation + ROCE Integrity
- ₹160 cr IPO capex creates the next earnings runway.
- But the real trigger is not commissioning assets,
it's converting capacity into high-turn ROCE delivery.
▪️ Brownfield starts Q4 FY26
▪️ Greenfield Q2 FY27
▪️ Historical ROCE band: 20 to 25%
➡️ If ROCE stays intact while scale rises, this becomes a quality compounder, not a growth spike story.
3 | Sunrise Mix Shift – Where Orders Come From Matters More Than Size
- The market will reward EPACK not for volume, but where volume comes from.
▪️ Solar manufacturing plants
▪️ EV + battery infra
▪️ Data centres
▪️ FMCG automation
▪️ Logistics warehousing
- These sectors offer:
▪️Faster decision cycles
▪️Higher ticket sizes
▪️Recurring order potential
➡️ As the mix tilts toward these verticals, margin durability improves and valuation ceiling shifts upward.
🧭 Investor Compass Takeaway
- This rerating is execution validated, not narrative driven.
- The inflection point comes if EPACK simultaneously:
▪️Takes share in the PEB market
▪️Monetises new capacity without ROCE dilution
▪️Grows exposure to sunrise manufacturing & infra themes
No Buy/Sell recommendation
#StocksInFocus #StocksToWatch #Epackfrefab #PEB